Advertisement
Research Article| Volume 240, ISSUE 2, P345-350, June 2015

The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China

      Highlights

      • The study showed that MS and its components were positively correlated with baPWV.
      • Monitoring baPWV for MS patients is helpful to identify early stage of atherosclerosis.
      • The development of atherosclerosis can be delayed by controlling MS.

      Abstract

      Background

      Brachial-ankle pulse wave velocity (baPWV) can reflect both central and peripheral arterial stiffness. Metabolic syndrome (MS) and its components may increase arterial stiffness and the risks of cardiovascular diseases. However, the correlation of MS and its components with arterial stiffness has not been not well studied. The aim of this study was to investigate the correlation between MS/its components and arterial stiffness by the measurement of baPWV in south China population.

      Methods

      A total of 8599 subjects were selected from those who underwent health examination in our hospital. MS was defined by Joint Scientific Statement. BaPWV, waist circumference, blood pressure (BP), fasting plasma glucose (FPG), lipid profile and serum uric acid (UA) were measured. The relationship between baPWV and MS/its components was analyzed.

      Results

      BaPWV was significantly higher in the subjects with MS than in those without MS (P < 0.001 for both genders). By multivariate regression analysis, all the metabolic components were correlated to baPWV in the male and female subjects except low HDL-C and high UA in the male group. BP and FPG had the strongest correlation factors. The values of baPWV were positively correlated with the advanced age (P < 0.001) and the values of the MS components, and this correlation was stronger in the females than in the males (P < 0.001).

      Conclusion

      Metabolic syndrome and its individual components were positively correlated with baPWV. Monitoring baPWV is helpful to identify early stage of arterial stiffness in those people with MS.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Roger V.L.
        • Go A.S.
        • Lloyd-Jones D.M.
        • et al.
        American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2011 update: a report from the American heart association.
        Circulation. 2011; 123: e18-209
        • Chen W.
        • Gao R.
        • Lin L.
        • Zhu M.
        • Wang W.
        • et al.
        The report of Chinese CVD in 2013.
        Chin. Circulation J. 2014; 29: 487-491
        • Alberti
        • et al.
        Harmonizing the metabolic syndrome.
        Circulation. 2009; 120: 1640-1645
        • Siplä Kalle
        • Koivistoinen Teemu
        • Moilanen Leena
        • et al.
        Metabolic syndrome and arterial stiffness:The health 2000 survey.
        Metabolism Clin. Exp. 2007; 56: 320-326
        • Tsubakimoto Akilo
        • Saito Isao
        • Mannami Toshifumi
        • Naito Yoshihiko
        • et al.
        Impact of metabolic syndrome on brachial-ankle pulse wave velocity in Japanese.
        Hypertens. Res. 2006; 29: 29-37
        • Yamashina A.
        • Tomiyama H.
        • Takeda K.
        • Tsuda H.
        • Arai T.
        • Hirose K.
        • Koji Y.
        • Hori S.
        • Yamamoto Y.
        Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement.
        Hypertens. Res. 2002; 25: 359-364
        • Im J.A.
        • Lee J.W.
        • Shim J.Y.
        • Lee H.R.
        • Lee D.C.
        Association between brachial-ankle pulse wave velocity and cardiovascular risk factors in healthy adolescents.
        J. Pediatr. 2007; 150: 247-251
        • Nakanishi N.
        • Shiraishi T.
        • Wada M.
        Brachial-ankle pulse wave velocity and metabolic syndrome in a Japanese population: the minoh study.
        Hypertens. Res. 2005; 28: 125-131
        • Henry R.M.
        • Ferreira I.
        • Dekker J.M.
        • et al.
        The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance–The hoorn study.
        J. Hum. Hypertens. 2009; 23: 718-727
        • Nam J.S.
        • Park J.S.
        • Cho M.H.
        • et al.
        The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
        Diabetes Res. Clin. Pract. 2009; 84: 145-151
        • Satoh H.
        • Kishi R.
        • Tsutsui H.
        Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects.
        Hypertens. Res. 2009; 32: 1067-1071
        • Hirashiki A.
        • Murohara T.
        The impact of pulse wave velocity in a Japanese population with metabolic syndrome.
        Hypertens. Res. 2009; 32: 1045-1046
        • Wang Jin-Wen
        • Zhou Zi-Qiang
        • Hu Da-Yi
        Prevalence of arterial stiffness in North China, and associations with risk factors of cardiovascular disease:a community-based study.
        BMC Cardiovasc. Disord. 2012; 12: 119-127
        • Sabio J.M.
        • Vargas-Hitos J.
        • Zamora-Pasadas M.
        • Mediavilla J.D.
        • Navarrete N.
        • Ramirez A.
        • Hidalgo-Tenorio C.
        • Jaimez L.
        • Martin J.
        • Jimenez-Alonso J.
        Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
        J. Rheumatol. 2009; 36: 2204-2211
        • Nagasaki T.
        • Inaba M.
        • Yamada S.
        • Kumeda Y.
        • Hiura Y.
        • Nishizawa Y.
        Changes in brachial-ankle pulse wave velocity in subclinical hypothyroidism during normalization of thyroid function.
        Biomed. Pharmacother. 2007; 61: 482-487
        • Lee M.H.
        • Yoo Sun K.
        • Jee S.H.
        • Kim Jungchae
        The association between pulse wave velocity and metabolic syndrome in Korean.
        Disabil. Rehabilitation: Assistive Technol. 2013; 8: 140-144
        • Kim Young-Kwon
        Impact of the metabolic syndrome and its components on pulse wave velocity.
        Korean J. Intern. Med. 2006; 21: 109-115
        • Weng Chunyan
        • Yuan Hong
        • Tang Xiaohong
        • Huang Zhijun
        • Yang Kan
        • Chen Wei
        • Pingting
        • Chen Zhiheng
        • Chen Fangping
        Age- and gender dependent association between components of metabolic syndrome and subclinical arterial stiffness in a chinese population.
        Int. J. Med. Sci. 2012; 9: 730-737
        • Scuteri Angelo
        • Cunha Pedro G.
        • Agabiti Rosei E.
        • et al.
        Arterial stiffness and influences of the metabolic syndrome: A cross-countries study.
        Atherosclerosis. 2014; 233: 654-660
        • Tomiyama H.
        • Yamashina A.
        • Arai T.
        • Hirose K.
        • Koji Y.
        • Chikamori T.
        • et al.
        Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement: a survey of 12517 subjects.
        Atherosclerosis. 2003; 166: 303-309
        • Laogun A.A.
        • Gosling R.G.
        In vivo arterial compliance in man.
        Clin. Phys. Physiol. Meas. 1982; 3: 201-212
        • Avolio A.P.
        • Chen S.G.
        • Wang R.P.
        • et al.
        Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community.
        Circulation. 1983; 68: 50-58
        • Avolio A.P.
        • Fa-Quan D.
        • Wei-Quiang L.
        • et al.
        Effects of aging on changing arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China.
        Circulation. 1985; 71: 202-210
        • Tanaka H.
        • Dinenno F.A.
        • Monahan K.D.
        • DeSouza C.A.
        • Seals D.R.
        Carotid artery wall hypertrophy with age is related to local systolic blood pressure in healthy men.
        Arterioscler. Thromb. Vasc. Biol. 2001; 21: 82-87
        • Tracy R.E.
        Medial thickenings of coronary artery and the aging risk factor for atherosclerosis.
        Atherosclerosis. 2001; 155: 337-346
        • Weng C.
        • Yuan H.
        • Yang K.
        • Tang X.
        • et al.
        Gender-specific association between the metabolic syndrome and arterial stiffness in 8300 subjects.
        Am. J. Med. Sci. 2013; 346: 289-294
        • Kass D.A.
        Ventricular arterial stiffening:integrating the pathophysiology.
        Hypertension. 2005; 46: 185-193
        • Aronson Doron
        Hyperglycemia and the pathobiology of diabetic complications.
        Facets. Adv. Cardiol. Basel. 2008; (Karger): 1-16
        • Khera A.V.
        • Cuchel M.
        • de la Llera-Moya M.
        • et al.
        Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
        N. Engl. J. Med. 2011; 364: 127-135
        • Schwartz G.G.
        • Olsson A.G.
        • Abt M.
        • Ballantyne C.M.
        • Barter P.J.
        • Brumm J.
        • et al.
        Effects of dalcetrapib in patients with a recent acute coronary syndrome.
        N. Engl. J. Med. 2012; 367: 2089-2099
        • Barter P.J.
        • Caulfield M.
        • Eriksson M.
        • Grundy S.M.
        • Kastelein J.J.
        • Komajda M.
        • et al.
        Effects of torcetrapib in patients at high risk for coronary events.
        N. Engl. J. Med. 2007; 357: 2109-2122
        • Boden W.E.
        • Probstfield J.L.
        • Anderson T.
        • Chaitman B.R.
        • Desvignes-Nickens P.
        • Koprowicz K.
        • et al.
        Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
        N. Engl. J. Med. 2011; 365: 2255-2267
        • Ginsberg H.N.
        • Elam M.B.
        • Lovato L.C.
        • Crouse 3rd, J.R.
        • Leiter L.A.
        • Linz P.
        • et al.
        Effects of combination lipid therapy in type 2 diabetes mellitus.
        N. Engl. J. Med. 2010; 362: 1563-1574
        • Keech A.
        • Simes R.J.
        • Barter P.
        • Best J.
        • Scott R.
        • Taskinen M.R.
        • et al.
        Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
        Lancet. 2005; 366: 1849-1861
        • Von Eckardstein A.
        Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?.
        Expert Rev. Cardiovasc Ther. 2010; 8: 345-358
        • Rosenson R.S.
        • Brewer Jr., H.B.
        • Davidson W.S.
        • Fayad Z.A.
        • Fuster V,Goldstein J.
        • et al.
        Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.
        Circulation. 2012; 125: 1905-1919
        • Rosenson R.S.
        • Brewer Jr., H.B.
        • Chapman M.J.
        • Fazio S.
        • Hussain M.M.
        • Kontush A.
        • et al.
        HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.
        Clin. Chem. 2011; 57: 392-410
        • Rye K.A.
        • Barter P.J.
        Predictive value of different HDL particles for the protection against or risk of coronary heart disease.
        Biochim. Biophys. Acta. 1821; 2012: 473-480
        • Superko H.R.
        • Pendyala L.
        • Williams P.T.
        • Momary K.M.
        • King 3rd, S.B.
        • Garrett B.C.
        High-density lipoprotein subclasses and their relationship to cardiovascular disease.
        J. Clin. Lipidol. 2012; 6: 496-523
        • Otvos J.D.
        • Collins D.
        • Freedman D.S.
        • Shalaurova I.
        • Schaefer E.J.
        • McNamara J.R.
        • et al.
        Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial.
        Circulation. 2006; 113: 1556-1563
        • Chei C.L.
        • Yamagishi K.
        • Kitamura A.
        • Kiyama M.
        • Imano H.
        • Ohira T.
        • et al.
        High-density lipoprotein subclasses and risk of stroke and its subtypes in Japanese population: the circulatory risk in communities study.
        Stroke. 2013; 44: 327-333
        • Wurtz P.
        • Raiko J.R.
        • Magnussen C.G.
        • Soininen P.
        • Kangas A.J.
        • Tynkkynen T.
        • et al.
        High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis.
        Eur. Heart J. 2012; 33: 2307-2316
        • El Harchaoui K.
        • Arsenault B.J.
        • Franssen R.
        • Despres J.P.
        • Hovingh G.K.
        • Stroes E.S.
        • et al.
        High-density lipoprotein particle size and concentration and coronary risk.
        Ann. Intern Med. 2009; 150: 84-93
        • Mora S.
        • Otvos J.D.
        • Rifai N.
        • Rosenson R.S.
        • Buring J.E.
        • Ridker P.M.
        Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
        Circulation. 2009; 119: 931-939
        • Berger J.S.
        • McGinn A.P.
        • Howard B.V.
        • Kuller L.
        • Manson J.E.
        • Otvos J.
        • et al.
        Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women.
        Stroke. 2012; 43: 958-966
        • Bae J.S.
        • Shin D.H.
        • Park P.S.
        • Choi B.Y.
        • Kim M.K.
        • et al.
        The impact of serum uric acid level on arterial stiffness and carotid atherosclerosis: the Korean multi-rural communities cohort study.
        Atherosclerosis. 2013; 231: 145-151
        • Fang J.I.
        • Wu J.S.
        • Yang Y.C.
        • Wang R.H.
        • Lu F.H.
        • Chang C.J.
        • et al.
        High uric acid level associated with increased arterial stiffness in apparently healthy women.
        Atherosclerosis. 2014; 236: 389-393
        • Ishi Zaka N.
        • Ishizaka Y.
        • Toda E.I.
        • Hashimoto H.
        • Nagai R.
        • Yamakado M.
        Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals.
        Atherosclerosis. 2007; 192: 131-137
        • Bian S.
        • Guo H.
        • Ye P.
        • Luo L.
        • Wu H.
        • Xiao W.
        • et al.
        Serum uric acid level and diverse impacts on regional arterial stiffness and wave reflection.
        Iran. J. Publ. Health. 2012; 41: 33-41
        • Lim J.H.
        • Kim Y.S.
        • Na S.H.
        • Rhee M.Y.
        • Lee M.M.
        Relationship between serum uric acid levels, metabolic syndrome,and arterial stiffness in Korean.
        Korean Circ. J. 2010; 40: 314-320
        • Kolz M.
        • Johnson T.
        • Sanna S.
        • Teumer A.
        • Vitart V.
        • Perola M.
        • Mangino M.
        • et al.
        Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.
        PLoS Genet. 2009; 5 (e1000504)
        • Nakagawa N.
        • Takahashi F.
        • Chinda J.
        • Kobayashi M.
        • Hayashi Y.
        • et al.
        A newly estimated glomerular filtration rate is independently associated with arterial stiffness in Japanese patients.
        Hypertens. Res. 2009; 31: 193-201